Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Carvedilol Posology on Clinically Significant Portal Hypertension: Insights From Elastography Measurements

NCT06015373 is registered in ClinicalTrials.gov with Centro Hospitalar De São João, E.P.E. as lead sponsor.

NCT NCT06015373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06015373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Carvedilol Posology on Clinically Significant Portal Hypertension: Insights From Elastography Measurements
Lead sponsor
Centro Hospitalar De São João, E.P.E.
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2023
Completion date
July 31, 2023
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinically significant portal hypertension